P

Precipio
D

PRPO

14.700
USD
0.46
(3.23%)
مغلق
حجم التداول
339
الربح لكل سهم
0
العائد الربحي
-
P/E
-7
حجم السوق
22,226,562
أصول ذات صلة
B
BNGO
-0.22500
(-7.00%)
2.99000 USD
E
EXAS
0.580
(1.29%)
45.590 USD
F
FATE
0.00000
(0.00%)
1.08000 USD
NTRA
NTRA
4.540
(2.86%)
163.020 USD
R
RDHL
-0.04500
(-3.21%)
1.35500 USD
V
VCYT
0.180
(0.60%)
30.220 USD
المزيد
الأخبار المقالات

العنوان: Precipio

القطاع: Healthcare
الصناعة: Diagnostics & Research
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.